Xianfu Wu

Dr. Xianfu Wu

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2012 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
JLJian Li
Jian Li
XWXianfu Wu
Xianfu Wu
GDGang Ding
Gang Ding
YFYu Feng
Yu Feng
XJXuejun Jiang
Xuejun Jiang
YCYongsheng Che
Yongsheng Che

11 February 2025 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
YWYongjian Wang
Yongjian Wang
YWYadan Wang
Yadan Wang
ZZZhongmou Zhang
Zhongmou Zhang
KXKailing Xu
Kailing Xu
QFQiufang Fang
Qiufang Fang
SMShuangcheng Ma
Shuangcheng Ma

15 January 2024 in Molecules
Verified
Journal Article
Open access
PDF file
XDXiao-Nan Du
Xiao-Nan Du
YHYu He
Yu He
YCYouwen Chen
Youwen Chen
QLQian Liu
Qian Liu
LSLei Sun
Lei Sun
YLYong Lu
Yong Lu
Despite advancements in analytical technologies, the complex nature of cosmetic matrices, coupled with the presence of diverse and trace unauthorized additives, hinders the application of these technologies in cosmetics analysis. This not only impedes effective regulation of cosmetics but also leads to the continual infiltration of illegal products into the market, posing serious health risks to consumers. The establishment of cosmetic regulations is often based on extensive scientific experiments, resulting in a certain degree of latency. Therefore, timely advancement in laboratory research is crucial to ensure the timely update and adaptability of regulations. A comprehensive understanding of the composition of cosmetic matrices and their pretreatment technologies is vital for enhancing the efficiency and accuracy of cosmetic detection. Drawing upon the China National Medical Products Administration’s 2021 Cosmetic Classification Rules and Classification Catalogue, we streamline the wide array of cosmetics into four principal categories based on the following compositions: emulsified, liquid, powdered, and wax-based cosmetics. In this review, the characteristics, compositional elements, and physicochemical properties inherent to each category, as well as an extensive overview of the evolution of pretreatment methods for different categories, will be explored. Our objective is to provide a clear and comprehensive guide, equipping researchers with profound insights into the core compositions and pretreatment methods of cosmetics, which will in turn advance cosmetic analysis and improve detection and regulatory approaches in the industry.

17 May 2023 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
YLYong Lu
Yong Lu
YGYaqing Guo
Yaqing Guo
YZYajun Zhang
Yajun Zhang
HSHuimin Sun
Huimin Sun
XWXianfu Wu
Xianfu Wu

26 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
YWYadan Wang
Yadan Wang
JYJiangong Yan
Jiangong Yan
ZZZhongmou Zhang
Zhongmou Zhang
MCMinghui Chen
Minghui Chen
XWXianfu Wu
Xianfu Wu
SMShuangcheng Ma
Shuangcheng Ma
Tripterygium wilfordii Hook. f. is a well-known traditional Chinese medicine used to treat autoimmune diseases. Sesquiterpene pyridine alkaloids (SPAs) are a major class of components found in this herb that have piqued the interest of researchers due to their complex and diverse structures as well as significant biological activities. In this study, ten new SPAs, wilfordatine A–J (1–10), were isolated from the roots of T. wilfordii, along with ten known analogues (11–20). Their structures were primarily elucidated by extensive 1D and 2D NMR spectroscopic analysis. To search for more immunosuppressive ingredients related to the clinical efficacy of T. wilfordii, the total alkaloids (TA) and compounds 4, 5, and 9–16 were tested for their inhibitory effects on nuclear factor-kappa B (NF-κB) pathway in Lipopolysaccharide (LPS) induced HEK293/NF-κB-Luc cells. Among them, TA, compounds 5, 11, and 16 showed potent immunosuppressive activity, with IC50 values of 7.25 μg/mL, 8.75 μM, 0.74 μM, and 15.66 μM, respectively, and no influence on the cell viability at a concentration of 100 μg/mL (TA) or 100 μM (5, 11, and 16). Accordingly, TA, 5, 11, and 16, especially 11, were identified as promising candidates for further investigation into their potential use as immunosuppressive agents.

23 May 2017 in Molecules
Verified
Journal Article
Open access
PDF file
XWXianfu Wu
Xianfu Wu
Li LiLi Li
Li Li
YLYong Li
Yong Li
HLHai-Ning Lv
Hai-Ning Lv
YLYun-Bao Liu
Yun-Bao Liu
YHYou-Cai Hu
You-Cai Hu
Two new phloroglucinols, lysidisides X and Y (1 and 2), and two known compounds, 2-(2-methylbutyryl)phloroglucinol 1-O-β-d-glucopyranoside (3) and (E)-resveratrol 3-(6″-galloyl)-O-β-d-glucopyranoside (4), have been isolated from the roots of Lysidice rhodostegia. The structures of 1 and 2 were elucidated primarily by NMR experiments. Their absolute configurations were deduced via circular dichroism (CD) data and electronic circular dichroism (ECD) calculations. Compounds 1 and 2 exhibited significant antioxidative activities with IC50 values of 12.0 and 11.8 µM, respectively.